LAL assay: < 0.5 EU/mg, every lot.
Bacterial endotoxin contamination silently kills cell-line experiments and confounds every downstream assay. We screen every peptide release with kinetic chromogenic LAL well below the 5 EU/mg pharmacopoeial limit.
Six steps from sample aliquot to released lot.
The LAL assay is unforgiving — a single contaminated tip or a moisture-traced glass vial can produce a false positive. Every step below is built around eliminating those failure modes before the result is reported.
-
01
Depyrogenated workspace
All glassware baked at 250 °C for ≥ 30 minutes (LAL water-equivalent depyrogenation). Pipette tips and microplates are certified endotoxin-free (< 0.005 EU/device). Hood is wiped with LAL-grade water before setup.
-
02
Sample dilution
2 mg of peptide reconstituted in 2 mL LAL-grade water (1 mg/mL stock). Serial 1:10 dilutions prepared down to 0.001 mg/mL — span the standard curve and check for assay inhibition or enhancement at multiple concentrations.
-
03
Standard curve setup
Control Standard Endotoxin (CSE, lot-traceable to RSE) diluted in LAL-grade water across 5 points: 50, 5, 0.5, 0.05, 0.005 EU/mL. Each standard runs in triplicate. Negative control (LAL water blank) and PPC (positive product control) wells are added.
-
04
LAL reagent & substrate
50 µL of pre-warmed sample + 50 µL of LAL reagent + chromogenic substrate (Boc-Leu-Gly-Arg-pNA) added per well. Plate sealed, transferred to plate reader pre-equilibrated to 37 °C ± 0.5 °C.
-
05
Kinetic read
Absorbance at 405 nm recorded every 30 seconds for up to 90 minutes. Onset time defined as the moment absorbance crosses the threshold (ΔOD ≥ 0.2 above blank). Faster onset = higher endotoxin.
-
06
Regression & release
Standard curve fitted log/log; R² must be ≥ 0.98. PPC recovery must fall in 50–200%. Sample concentration back-calculated, normalised to peptide mass. ≤ 0.5 EU/mg: released. Above: rejected and synthesis batch investigated.
One standard curve, one sample point, two reference lines.
Every release is a single point on a freshly-fitted regression line. The slope, the intercept, the R², the recovery — all four have to clear before the back-calculated concentration is even reported.
Standard curve (5-point)
Five-point CSE dilution from <b>50 EU/mL</b> down to <b>0.005 EU/mL</b>. Log/log regression slope ≈ −0.31, R² = <b>0.9994</b>. Each standard runs in triplicate to lock the curve before any sample is fitted.
Sample & back-calculation
Sample onset time falls between 0.05 and 0.5 EU/mL standards. Back-calculated to <b>0.18 EU/mg</b> after correcting for dilution and peptide mass — well inside the 0.5 EU/mg release ceiling.
Reference lines
<b>Yellow dashed</b>: assay LOD at 0.005 EU/mL. <b>Red dashed</b>: 0.5 EU/mg release ceiling. Anything between them is reportable; anything to the right of red triggers an immediate rejection notice.
Reagent, plate, kinetic read, acceptance.
The full kinetic chromogenic LAL setup, exactly as the contract lab runs it. USP <85> / EP 2.6.14 compliant.
Reagent & reference
| Lysate | Limulus polyphemus, kinetic chromogenic |
|---|---|
| Sensitivity (λ) | 0.005 EU/mL |
| CSE reference | Lot-traceable to USP RSE |
| Substrate | Boc-Leu-Gly-Arg-pNA, chromogenic |
| LAL water | < 0.005 EU/mL certified |
| Compendial method | USP <85> / EP 2.6.14 |
Plate & sample
| Plate format | 96-well, certified pyrogen-free |
|---|---|
| Sample volume | 50 µL per well |
| Reagent volume | 50 µL per well |
| Standards | 5 points, triplicate (15 wells) |
| Sample dilutions | 4 levels (1:10 series) |
| PPC wells | 2 per sample dilution |
Kinetic read
| Wavelength | 405 nm |
|---|---|
| Temperature | 37 °C ± 0.5 °C |
| Read interval | Every 30 seconds |
| Maximum run time | 90 minutes |
| Onset threshold | ΔOD ≥ 0.2 above blank |
| Curve fit | Log/log linear regression |
Acceptance criteria
| Standard curve R² | ≥ 0.98 |
|---|---|
| Slope window | −0.20 to −0.45 |
| PPC recovery | 50% – 200% |
| Negative control | Onset > 90 min (no signal) |
| Sample dilutions | 2 must agree within 50% |
| Release ceiling | ≤ 0.5 EU/mg |
The number on the COA, translated to your bench.
0.5 vs. 0.05 EU/mg sounds incremental on a label — until you trace what reaches the cells. Concrete numbers below assume a 1 mg/mL stock reconstituted, then diluted to 100 nM in a typical 5 mL well.
Acceptable for parenteral pharmacopoeia, catastrophic for cell biology. Primary cultures and immune assays will produce phantom signals attributed to the test compound.
Standard floor for vendors who test at all. Cell line work is mostly fine; anything involving primary monocytes, macrophages or DC is confounded.
Hard ceiling — anything above is rejected and the synthesis batch is investigated. Below the activation threshold of TLR4 in HEK-Blue reporter assays.
Where most of our actual lots land. Effectively endotoxin-free for in-vitro work, including primary cultures and innate-immunity assays.
The five contamination paths the LAL number catches.
Endotoxin is not a synthesis byproduct — it's an ingress from somewhere in the chain. Every COA tests the lot for it; understanding the source is what keeps the number low batch after batch.
Four conditions that void the assay or reject the lot.
The release decision is binary and the assay itself has its own pass/fail criteria. If either chain breaks, the result is not reported — the run is repeated or the batch is sent back.
Sample > 0.5 EU/mg
The release ceiling. Anything above and the lot is rejected, the synthesis line is investigated for the contamination source, and the contract lab re-tests after corrective action. There is no "sell as research-grade" downgrade.
PPC recovery outside 50–200%
Positive product control verifies the peptide matrix is not inhibiting or enhancing the LAL cascade. Recovery outside 50–200% means the result is not interpretable; the sample is re-diluted and the assay re-run before any number is reported.
Standard curve R² < 0.98
Below 0.98 the regression is not tight enough for back-calculation to be defensible. The standards are re-prepared from the CSE stock, the plate is re-loaded, and the assay restarted. No sample read on a bad curve.
Negative control fires before 90 min
The blank well containing only LAL water + reagent must remain below threshold for the full 90-minute run. Any onset means the LAL water, reagent or hood is contaminated — the entire assay is voided and the materials sourced fresh.